In situ forming implants for the delivery of metronidazole to periodontal pockets: formulation and drug release studies

KILIÇARSLAN M., Koerber M., Bodmeier R.

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, cilt.40, sa.5, ss.619-624, 2014 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 40 Sayı: 5
  • Basım Tarihi: 2014
  • Doi Numarası: 10.3109/03639045.2013.873449
  • Dergi Adı: DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.619-624
  • Anahtar Kelimeler: Drug release, in situ implant, metronidazole, mucoadhesion, periodontal pocket, poly(lactide-co-glycolide), texture profile analyzer, LEUPROLIDE ACETATE, MUCOADHESIVE, VITRO, SYSTEMS, TETRACYCLINE, PLA, POLY(D,L-LACTIDE-CO-GLYCOLIDE), SYRINGEABILITY, MICROSPHERES, DOXYCYCLINE
  • Ankara Üniversitesi Adresli: Evet

Özet

This study was performed to obtain prolonged drug release with biodegradable in situ forming implants for the local delivery of metronidazole to periodontal pockets. The effect of polymer type (capped and uncapped PLGA), solvent type (water-miscible and water-immiscible) and the polymer/drug ratio on in vitro drug release studies were investigated. In situ implants with sustained metronidazole release and low initial burst consisted of capped PLGA and N-methyl-2-pyrolidone as solvent. Mucoadhesive polymers were incorporated into the in situ implants in order to modify the properties of the delivery systems towards longer residence times in vivo. Addition of the polymers changed the adhesiveness and increased the viscosity and drug release of the formulations. However, sustained drug release over 10 days was achievable. Biodegradable in situ forming implants are therefore an attractive delivery system to achieve prolonged release of metronidazole at periodontal therapy.